nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CYP2E1—prostate cancer	0.164	0.614	CbGaD
Rufinamide—CES1—Capecitabine—prostate cancer	0.118	0.281	CbGbCtD
Rufinamide—CYP3A4—prostate cancer	0.103	0.386	CbGaD
Rufinamide—ALB—Abiraterone—prostate cancer	0.0405	0.0965	CbGbCtD
Rufinamide—CYP2E1—Estrone—prostate cancer	0.0303	0.0722	CbGbCtD
Rufinamide—ALB—Estrone—prostate cancer	0.0293	0.0698	CbGbCtD
Rufinamide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0292	0.0695	CbGbCtD
Rufinamide—CYP2E1—Mitoxantrone—prostate cancer	0.018	0.0429	CbGbCtD
Rufinamide—ALB—Estradiol—prostate cancer	0.0168	0.0401	CbGbCtD
Rufinamide—CYP3A4—Bicalutamide—prostate cancer	0.0153	0.0365	CbGbCtD
Rufinamide—ALB—Prednisone—prostate cancer	0.0145	0.0345	CbGbCtD
Rufinamide—CYP3A4—Estramustine—prostate cancer	0.0143	0.0339	CbGbCtD
Rufinamide—CYP3A4—Flutamide—prostate cancer	0.0127	0.0302	CbGbCtD
Rufinamide—CYP3A4—Abiraterone—prostate cancer	0.0127	0.0302	CbGbCtD
Rufinamide—CYP2E1—Etoposide—prostate cancer	0.0114	0.0271	CbGbCtD
Rufinamide—CYP3A4—Cabazitaxel—prostate cancer	0.0094	0.0224	CbGbCtD
Rufinamide—CYP3A4—Estrone—prostate cancer	0.00918	0.0219	CbGbCtD
Rufinamide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00819	0.0195	CbGbCtD
Rufinamide—CYP3A4—Conjugated Estrogens—prostate cancer	0.00601	0.0143	CbGbCtD
Rufinamide—CYP3A4—Mitoxantrone—prostate cancer	0.00546	0.013	CbGbCtD
Rufinamide—CYP3A4—Estradiol—prostate cancer	0.00527	0.0126	CbGbCtD
Rufinamide—CYP3A4—Prednisone—prostate cancer	0.00454	0.0108	CbGbCtD
Rufinamide—CYP3A4—Etoposide—prostate cancer	0.00344	0.0082	CbGbCtD
Rufinamide—CYP3A4—Docetaxel—prostate cancer	0.00315	0.0075	CbGbCtD
Rufinamide—SCN7A—prostate gland—prostate cancer	0.0025	0.0885	CbGeAlD
Rufinamide—CYP3A4—Doxorubicin—prostate cancer	0.00235	0.00559	CbGbCtD
Rufinamide—SCN9A—prostate gland—prostate cancer	0.00196	0.0693	CbGeAlD
Rufinamide—CYP2E1—urine—prostate cancer	0.00178	0.0633	CbGeAlD
Rufinamide—SCN4A—prostate gland—prostate cancer	0.00174	0.0618	CbGeAlD
Rufinamide—GRM5—testis—prostate cancer	0.00174	0.0617	CbGeAlD
Rufinamide—CES1—prostate gland—prostate cancer	0.00156	0.0552	CbGeAlD
Rufinamide—CYP3A4—urine—prostate cancer	0.00144	0.0509	CbGeAlD
Rufinamide—SCN3A—prostate gland—prostate cancer	0.00136	0.0481	CbGeAlD
Rufinamide—SCN4A—renal system—prostate cancer	0.00119	0.0421	CbGeAlD
Rufinamide—SCN7A—testis—prostate cancer	0.0011	0.039	CbGeAlD
Rufinamide—SCN8A—testis—prostate cancer	0.00098	0.0347	CbGeAlD
Rufinamide—SCN3A—renal system—prostate cancer	0.000925	0.0328	CbGeAlD
Rufinamide—SCN9A—testis—prostate cancer	0.000861	0.0305	CbGeAlD
Rufinamide—SCN7A—lymph node—prostate cancer	0.000797	0.0283	CbGeAlD
Rufinamide—SCN4A—testis—prostate cancer	0.000768	0.0272	CbGeAlD
Rufinamide—SCN3A—bone marrow—prostate cancer	0.000699	0.0248	CbGeAlD
Rufinamide—CES1—testis—prostate cancer	0.000686	0.0243	CbGeAlD
Rufinamide—CYP2E1—prostate gland—prostate cancer	0.000641	0.0227	CbGeAlD
Rufinamide—SCN9A—lymph node—prostate cancer	0.000624	0.0221	CbGeAlD
Rufinamide—SCN3A—testis—prostate cancer	0.000598	0.0212	CbGeAlD
Rufinamide—CYP2E1—seminal vesicle—prostate cancer	0.000542	0.0192	CbGeAlD
Rufinamide—CES1—lymph node—prostate cancer	0.000497	0.0176	CbGeAlD
Rufinamide—ALB—testis—prostate cancer	0.000477	0.0169	CbGeAlD
Rufinamide—SCN10A—lymph node—prostate cancer	0.000475	0.0168	CbGeAlD
Rufinamide—CYP2E1—renal system—prostate cancer	0.000437	0.0155	CbGeAlD
Rufinamide—SCN3A—lymph node—prostate cancer	0.000433	0.0154	CbGeAlD
Rufinamide—CYP2E1—urethra—prostate cancer	0.000429	0.0152	CbGeAlD
Rufinamide—CYP3A4—renal system—prostate cancer	0.000351	0.0125	CbGeAlD
Rufinamide—ALB—lymph node—prostate cancer	0.000346	0.0123	CbGeAlD
Rufinamide—CYP2E1—testis—prostate cancer	0.000282	0.01	CbGeAlD
Rufinamide—Constipation—Mitoxantrone—prostate cancer	0.000103	0.000605	CcSEcCtD
Rufinamide—Rash—Goserelin—prostate cancer	0.000102	0.000603	CcSEcCtD
Rufinamide—Dermatitis—Goserelin—prostate cancer	0.000102	0.000603	CcSEcCtD
Rufinamide—Vomiting—Conjugated Estrogens—prostate cancer	0.000102	0.000603	CcSEcCtD
Rufinamide—Mental disorder—Docetaxel—prostate cancer	0.000102	0.000603	CcSEcCtD
Rufinamide—Immune system disorder—Capecitabine—prostate cancer	0.000102	0.000602	CcSEcCtD
Rufinamide—Mediastinal disorder—Capecitabine—prostate cancer	0.000102	0.0006	CcSEcCtD
Rufinamide—Nasopharyngitis—Epirubicin—prostate cancer	0.000102	0.0006	CcSEcCtD
Rufinamide—Headache—Goserelin—prostate cancer	0.000102	0.0006	CcSEcCtD
Rufinamide—Malnutrition—Docetaxel—prostate cancer	0.000102	0.000599	CcSEcCtD
Rufinamide—Rash—Conjugated Estrogens—prostate cancer	0.000101	0.000598	CcSEcCtD
Rufinamide—Dermatitis—Conjugated Estrogens—prostate cancer	0.000101	0.000597	CcSEcCtD
Rufinamide—Headache—Conjugated Estrogens—prostate cancer	0.000101	0.000594	CcSEcCtD
Rufinamide—Infection—Etoposide—prostate cancer	9.91e-05	0.000584	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—prostate cancer	9.9e-05	0.000584	CcSEcCtD
Rufinamide—Mental disorder—Capecitabine—prostate cancer	9.9e-05	0.000583	CcSEcCtD
Rufinamide—Malnutrition—Capecitabine—prostate cancer	9.84e-05	0.00058	CcSEcCtD
Rufinamide—Influenza—Epirubicin—prostate cancer	9.83e-05	0.00058	CcSEcCtD
Rufinamide—Back pain—Docetaxel—prostate cancer	9.83e-05	0.000579	CcSEcCtD
Rufinamide—Thrombocytopenia—Etoposide—prostate cancer	9.77e-05	0.000576	CcSEcCtD
Rufinamide—Skin disorder—Etoposide—prostate cancer	9.69e-05	0.000571	CcSEcCtD
Rufinamide—Nausea—Goserelin—prostate cancer	9.64e-05	0.000569	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—prostate cancer	9.62e-05	0.000567	CcSEcCtD
Rufinamide—Nausea—Conjugated Estrogens—prostate cancer	9.55e-05	0.000563	CcSEcCtD
Rufinamide—Back pain—Capecitabine—prostate cancer	9.51e-05	0.000561	CcSEcCtD
Rufinamide—Breast disorder—Doxorubicin—prostate cancer	9.51e-05	0.000561	CcSEcCtD
Rufinamide—Anorexia—Etoposide—prostate cancer	9.51e-05	0.000561	CcSEcCtD
Rufinamide—Hypersensitivity—Estradiol—prostate cancer	9.48e-05	0.000559	CcSEcCtD
Rufinamide—Bronchitis—Epirubicin—prostate cancer	9.46e-05	0.000557	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—prostate cancer	9.41e-05	0.000555	CcSEcCtD
Rufinamide—Eye disorder—Prednisone—prostate cancer	9.41e-05	0.000554	CcSEcCtD
Rufinamide—Anaemia—Docetaxel—prostate cancer	9.39e-05	0.000553	CcSEcCtD
Rufinamide—Vision blurred—Capecitabine—prostate cancer	9.27e-05	0.000546	CcSEcCtD
Rufinamide—Asthenia—Estradiol—prostate cancer	9.24e-05	0.000544	CcSEcCtD
Rufinamide—Tremor—Capecitabine—prostate cancer	9.22e-05	0.000543	CcSEcCtD
Rufinamide—Dysuria—Epirubicin—prostate cancer	9.2e-05	0.000542	CcSEcCtD
Rufinamide—Neutropenia—Epirubicin—prostate cancer	9.2e-05	0.000542	CcSEcCtD
Rufinamide—Pruritus—Estradiol—prostate cancer	9.11e-05	0.000537	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—prostate cancer	9.1e-05	0.000536	CcSEcCtD
Rufinamide—Leukopenia—Docetaxel—prostate cancer	9.09e-05	0.000536	CcSEcCtD
Rufinamide—Anaemia—Capecitabine—prostate cancer	9.09e-05	0.000536	CcSEcCtD
Rufinamide—Immune system disorder—Prednisone—prostate cancer	9.09e-05	0.000536	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—prostate cancer	9.08e-05	0.000535	CcSEcCtD
Rufinamide—Weight decreased—Epirubicin—prostate cancer	8.9e-05	0.000524	CcSEcCtD
Rufinamide—Somnolence—Etoposide—prostate cancer	8.87e-05	0.000523	CcSEcCtD
Rufinamide—Vertigo—Capecitabine—prostate cancer	8.84e-05	0.000521	CcSEcCtD
Rufinamide—Hypersensitivity—Mitoxantrone—prostate cancer	8.84e-05	0.000521	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—prostate cancer	8.82e-05	0.00052	CcSEcCtD
Rufinamide—Mental disorder—Prednisone—prostate cancer	8.82e-05	0.00052	CcSEcCtD
Rufinamide—Diarrhoea—Estradiol—prostate cancer	8.81e-05	0.000519	CcSEcCtD
Rufinamide—Leukopenia—Capecitabine—prostate cancer	8.8e-05	0.000519	CcSEcCtD
Rufinamide—Convulsion—Docetaxel—prostate cancer	8.8e-05	0.000519	CcSEcCtD
Rufinamide—Infestation—Epirubicin—prostate cancer	8.77e-05	0.000517	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—prostate cancer	8.77e-05	0.000517	CcSEcCtD
Rufinamide—Malnutrition—Prednisone—prostate cancer	8.76e-05	0.000516	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—prostate cancer	8.75e-05	0.000516	CcSEcCtD
Rufinamide—Decreased appetite—Etoposide—prostate cancer	8.67e-05	0.000511	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Etoposide—prostate cancer	8.61e-05	0.000508	CcSEcCtD
Rufinamide—Asthenia—Mitoxantrone—prostate cancer	8.61e-05	0.000507	CcSEcCtD
Rufinamide—Fatigue—Etoposide—prostate cancer	8.6e-05	0.000507	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	8.59e-05	0.000506	CcSEcCtD
Rufinamide—Constipation—Etoposide—prostate cancer	8.53e-05	0.000503	CcSEcCtD
Rufinamide—Dizziness—Estradiol—prostate cancer	8.51e-05	0.000502	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—prostate cancer	8.51e-05	0.000502	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—prostate cancer	8.51e-05	0.000502	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—prostate cancer	8.41e-05	0.000495	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—prostate cancer	8.36e-05	0.000493	CcSEcCtD
Rufinamide—Anxiety—Capecitabine—prostate cancer	8.34e-05	0.000492	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	8.32e-05	0.00049	CcSEcCtD
Rufinamide—Hepatobiliary disease—Epirubicin—prostate cancer	8.29e-05	0.000489	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—prostate cancer	8.27e-05	0.000487	CcSEcCtD
Rufinamide—Vision blurred—Prednisone—prostate cancer	8.26e-05	0.000487	CcSEcCtD
Rufinamide—Infection—Docetaxel—prostate cancer	8.24e-05	0.000486	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—prostate cancer	8.23e-05	0.000485	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—prostate cancer	8.23e-05	0.000485	CcSEcCtD
Rufinamide—Diarrhoea—Mitoxantrone—prostate cancer	8.21e-05	0.000484	CcSEcCtD
Rufinamide—Vomiting—Estradiol—prostate cancer	8.18e-05	0.000482	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—prostate cancer	8.16e-05	0.000481	CcSEcCtD
Rufinamide—Nervous system disorder—Docetaxel—prostate cancer	8.13e-05	0.000479	CcSEcCtD
Rufinamide—Thrombocytopenia—Docetaxel—prostate cancer	8.12e-05	0.000478	CcSEcCtD
Rufinamide—Rash—Estradiol—prostate cancer	8.12e-05	0.000478	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—prostate cancer	8.11e-05	0.000478	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—prostate cancer	8.11e-05	0.000478	CcSEcCtD
Rufinamide—Dermatitis—Estradiol—prostate cancer	8.11e-05	0.000478	CcSEcCtD
Rufinamide—Anaemia—Prednisone—prostate cancer	8.1e-05	0.000477	CcSEcCtD
Rufinamide—Headache—Estradiol—prostate cancer	8.06e-05	0.000475	CcSEcCtD
Rufinamide—Skin disorder—Docetaxel—prostate cancer	8.05e-05	0.000475	CcSEcCtD
Rufinamide—Agitation—Prednisone—prostate cancer	8.05e-05	0.000475	CcSEcCtD
Rufinamide—Infection—Capecitabine—prostate cancer	7.97e-05	0.00047	CcSEcCtD
Rufinamide—Anorexia—Docetaxel—prostate cancer	7.9e-05	0.000466	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—prostate cancer	7.89e-05	0.000465	CcSEcCtD
Rufinamide—Nervous system disorder—Capecitabine—prostate cancer	7.87e-05	0.000464	CcSEcCtD
Rufinamide—Vertigo—Prednisone—prostate cancer	7.87e-05	0.000464	CcSEcCtD
Rufinamide—Thrombocytopenia—Capecitabine—prostate cancer	7.86e-05	0.000463	CcSEcCtD
Rufinamide—Skin disorder—Capecitabine—prostate cancer	7.8e-05	0.00046	CcSEcCtD
Rufinamide—Urinary tract disorder—Epirubicin—prostate cancer	7.77e-05	0.000458	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—prostate cancer	7.74e-05	0.000456	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—prostate cancer	7.72e-05	0.000455	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—prostate cancer	7.67e-05	0.000452	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—prostate cancer	7.65e-05	0.000451	CcSEcCtD
Rufinamide—Anorexia—Capecitabine—prostate cancer	7.65e-05	0.000451	CcSEcCtD
Rufinamide—Nausea—Estradiol—prostate cancer	7.65e-05	0.000451	CcSEcCtD
Rufinamide—Vomiting—Mitoxantrone—prostate cancer	7.63e-05	0.00045	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—prostate cancer	7.61e-05	0.000449	CcSEcCtD
Rufinamide—Convulsion—Prednisone—prostate cancer	7.59e-05	0.000447	CcSEcCtD
Rufinamide—Rash—Mitoxantrone—prostate cancer	7.56e-05	0.000446	CcSEcCtD
Rufinamide—Dermatitis—Mitoxantrone—prostate cancer	7.56e-05	0.000445	CcSEcCtD
Rufinamide—Headache—Mitoxantrone—prostate cancer	7.51e-05	0.000443	CcSEcCtD
Rufinamide—Insomnia—Docetaxel—prostate cancer	7.5e-05	0.000442	CcSEcCtD
Rufinamide—Anxiety—Prednisone—prostate cancer	7.43e-05	0.000438	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	7.41e-05	0.000437	CcSEcCtD
Rufinamide—Somnolence—Docetaxel—prostate cancer	7.37e-05	0.000434	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—prostate cancer	7.36e-05	0.000434	CcSEcCtD
Rufinamide—Hypersensitivity—Etoposide—prostate cancer	7.35e-05	0.000433	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—prostate cancer	7.31e-05	0.000431	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—prostate cancer	7.3e-05	0.00043	CcSEcCtD
Rufinamide—Dyspepsia—Docetaxel—prostate cancer	7.3e-05	0.00043	CcSEcCtD
Rufinamide—Insomnia—Capecitabine—prostate cancer	7.26e-05	0.000428	CcSEcCtD
Rufinamide—Decreased appetite—Docetaxel—prostate cancer	7.21e-05	0.000425	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—prostate cancer	7.19e-05	0.000424	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Docetaxel—prostate cancer	7.16e-05	0.000422	CcSEcCtD
Rufinamide—Asthenia—Etoposide—prostate cancer	7.16e-05	0.000422	CcSEcCtD
Rufinamide—Fatigue—Docetaxel—prostate cancer	7.15e-05	0.000421	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—prostate cancer	7.14e-05	0.000421	CcSEcCtD
Rufinamide—Nausea—Mitoxantrone—prostate cancer	7.12e-05	0.00042	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—prostate cancer	7.11e-05	0.000419	CcSEcCtD
Rufinamide—Infection—Prednisone—prostate cancer	7.1e-05	0.000419	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—prostate cancer	7.09e-05	0.000418	CcSEcCtD
Rufinamide—Constipation—Docetaxel—prostate cancer	7.09e-05	0.000418	CcSEcCtD
Rufinamide—Dyspepsia—Capecitabine—prostate cancer	7.07e-05	0.000417	CcSEcCtD
Rufinamide—Pruritus—Etoposide—prostate cancer	7.06e-05	0.000416	CcSEcCtD
Rufinamide—Nervous system disorder—Prednisone—prostate cancer	7.01e-05	0.000413	CcSEcCtD
Rufinamide—Decreased appetite—Capecitabine—prostate cancer	6.98e-05	0.000411	CcSEcCtD
Rufinamide—Skin disorder—Prednisone—prostate cancer	6.95e-05	0.000409	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Capecitabine—prostate cancer	6.93e-05	0.000409	CcSEcCtD
Rufinamide—Fatigue—Capecitabine—prostate cancer	6.92e-05	0.000408	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—prostate cancer	6.9e-05	0.000406	CcSEcCtD
Rufinamide—Constipation—Capecitabine—prostate cancer	6.86e-05	0.000405	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—prostate cancer	6.85e-05	0.000404	CcSEcCtD
Rufinamide—Diarrhoea—Etoposide—prostate cancer	6.83e-05	0.000402	CcSEcCtD
Rufinamide—Anorexia—Prednisone—prostate cancer	6.82e-05	0.000402	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—prostate cancer	6.81e-05	0.000401	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—prostate cancer	6.76e-05	0.000398	CcSEcCtD
Rufinamide—Back pain—Epirubicin—prostate cancer	6.63e-05	0.000391	CcSEcCtD
Rufinamide—Dizziness—Etoposide—prostate cancer	6.6e-05	0.000389	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—prostate cancer	6.58e-05	0.000388	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—prostate cancer	6.56e-05	0.000387	CcSEcCtD
Rufinamide—Insomnia—Prednisone—prostate cancer	6.47e-05	0.000381	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—prostate cancer	6.46e-05	0.000381	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—prostate cancer	6.38e-05	0.000376	CcSEcCtD
Rufinamide—Vomiting—Etoposide—prostate cancer	6.34e-05	0.000374	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—prostate cancer	6.34e-05	0.000374	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—prostate cancer	6.33e-05	0.000373	CcSEcCtD
Rufinamide—Agitation—Epirubicin—prostate cancer	6.3e-05	0.000371	CcSEcCtD
Rufinamide—Dyspepsia—Prednisone—prostate cancer	6.29e-05	0.000371	CcSEcCtD
Rufinamide—Rash—Etoposide—prostate cancer	6.29e-05	0.000371	CcSEcCtD
Rufinamide—Dermatitis—Etoposide—prostate cancer	6.28e-05	0.00037	CcSEcCtD
Rufinamide—Headache—Etoposide—prostate cancer	6.25e-05	0.000368	CcSEcCtD
Rufinamide—Decreased appetite—Prednisone—prostate cancer	6.22e-05	0.000366	CcSEcCtD
Rufinamide—Fatigue—Prednisone—prostate cancer	6.16e-05	0.000363	CcSEcCtD
Rufinamide—Vertigo—Epirubicin—prostate cancer	6.16e-05	0.000363	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—prostate cancer	6.13e-05	0.000362	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—prostate cancer	6.13e-05	0.000361	CcSEcCtD
Rufinamide—Constipation—Prednisone—prostate cancer	6.11e-05	0.00036	CcSEcCtD
Rufinamide—Hypersensitivity—Docetaxel—prostate cancer	6.11e-05	0.00036	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—prostate cancer	5.98e-05	0.000352	CcSEcCtD
Rufinamide—Asthenia—Docetaxel—prostate cancer	5.95e-05	0.000351	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—prostate cancer	5.94e-05	0.00035	CcSEcCtD
Rufinamide—Nausea—Etoposide—prostate cancer	5.93e-05	0.000349	CcSEcCtD
Rufinamide—Hypersensitivity—Capecitabine—prostate cancer	5.91e-05	0.000349	CcSEcCtD
Rufinamide—Pruritus—Docetaxel—prostate cancer	5.87e-05	0.000346	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—prostate cancer	5.86e-05	0.000345	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—prostate cancer	5.83e-05	0.000343	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—prostate cancer	5.81e-05	0.000343	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.79e-05	0.000341	CcSEcCtD
Rufinamide—Asthenia—Capecitabine—prostate cancer	5.76e-05	0.000339	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—prostate cancer	5.7e-05	0.000336	CcSEcCtD
Rufinamide—Pruritus—Capecitabine—prostate cancer	5.68e-05	0.000335	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—prostate cancer	5.68e-05	0.000335	CcSEcCtD
Rufinamide—Diarrhoea—Docetaxel—prostate cancer	5.67e-05	0.000334	CcSEcCtD
Rufinamide—Infection—Epirubicin—prostate cancer	5.56e-05	0.000327	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—prostate cancer	5.49e-05	0.000324	CcSEcCtD
Rufinamide—Diarrhoea—Capecitabine—prostate cancer	5.49e-05	0.000324	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—prostate cancer	5.48e-05	0.000323	CcSEcCtD
Rufinamide—Dizziness—Docetaxel—prostate cancer	5.48e-05	0.000323	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—prostate cancer	5.48e-05	0.000323	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—prostate cancer	5.43e-05	0.00032	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—prostate cancer	5.38e-05	0.000317	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.36e-05	0.000316	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—prostate cancer	5.33e-05	0.000314	CcSEcCtD
Rufinamide—Dizziness—Capecitabine—prostate cancer	5.31e-05	0.000313	CcSEcCtD
Rufinamide—Vomiting—Docetaxel—prostate cancer	5.27e-05	0.000311	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisone—prostate cancer	5.27e-05	0.000311	CcSEcCtD
Rufinamide—Rash—Docetaxel—prostate cancer	5.23e-05	0.000308	CcSEcCtD
Rufinamide—Dermatitis—Docetaxel—prostate cancer	5.22e-05	0.000308	CcSEcCtD
Rufinamide—Headache—Docetaxel—prostate cancer	5.19e-05	0.000306	CcSEcCtD
Rufinamide—Infection—Doxorubicin—prostate cancer	5.14e-05	0.000303	CcSEcCtD
Rufinamide—Asthenia—Prednisone—prostate cancer	5.13e-05	0.000302	CcSEcCtD
Rufinamide—Vomiting—Capecitabine—prostate cancer	5.1e-05	0.000301	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—prostate cancer	5.07e-05	0.000299	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—prostate cancer	5.07e-05	0.000299	CcSEcCtD
Rufinamide—Rash—Capecitabine—prostate cancer	5.06e-05	0.000298	CcSEcCtD
Rufinamide—Pruritus—Prednisone—prostate cancer	5.06e-05	0.000298	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—prostate cancer	5.06e-05	0.000298	CcSEcCtD
Rufinamide—Dermatitis—Capecitabine—prostate cancer	5.06e-05	0.000298	CcSEcCtD
Rufinamide—Headache—Capecitabine—prostate cancer	5.03e-05	0.000296	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—prostate cancer	5.03e-05	0.000296	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—prostate cancer	4.97e-05	0.000293	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—prostate cancer	4.93e-05	0.000291	CcSEcCtD
Rufinamide—Nausea—Docetaxel—prostate cancer	4.92e-05	0.00029	CcSEcCtD
Rufinamide—Dyspepsia—Epirubicin—prostate cancer	4.92e-05	0.00029	CcSEcCtD
Rufinamide—Diarrhoea—Prednisone—prostate cancer	4.89e-05	0.000288	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—prostate cancer	4.86e-05	0.000287	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—prostate cancer	4.83e-05	0.000285	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—prostate cancer	4.82e-05	0.000284	CcSEcCtD
Rufinamide—Constipation—Epirubicin—prostate cancer	4.78e-05	0.000282	CcSEcCtD
Rufinamide—Nausea—Capecitabine—prostate cancer	4.77e-05	0.000281	CcSEcCtD
Rufinamide—Dizziness—Prednisone—prostate cancer	4.73e-05	0.000279	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—prostate cancer	4.68e-05	0.000276	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—prostate cancer	4.6e-05	0.000271	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—prostate cancer	4.55e-05	0.000268	CcSEcCtD
Rufinamide—Vomiting—Prednisone—prostate cancer	4.55e-05	0.000268	CcSEcCtD
Rufinamide—Rash—Prednisone—prostate cancer	4.51e-05	0.000266	CcSEcCtD
Rufinamide—Dermatitis—Prednisone—prostate cancer	4.5e-05	0.000265	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—prostate cancer	4.5e-05	0.000265	CcSEcCtD
Rufinamide—Headache—Prednisone—prostate cancer	4.48e-05	0.000264	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.47e-05	0.000263	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—prostate cancer	4.46e-05	0.000263	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—prostate cancer	4.42e-05	0.000261	CcSEcCtD
Rufinamide—Nausea—Prednisone—prostate cancer	4.25e-05	0.00025	CcSEcCtD
Rufinamide—Hypersensitivity—Epirubicin—prostate cancer	4.12e-05	0.000243	CcSEcCtD
Rufinamide—Asthenia—Epirubicin—prostate cancer	4.01e-05	0.000237	CcSEcCtD
Rufinamide—Pruritus—Epirubicin—prostate cancer	3.96e-05	0.000233	CcSEcCtD
Rufinamide—Diarrhoea—Epirubicin—prostate cancer	3.83e-05	0.000226	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—prostate cancer	3.81e-05	0.000225	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—prostate cancer	3.71e-05	0.000219	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—prostate cancer	3.7e-05	0.000218	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—prostate cancer	3.66e-05	0.000216	CcSEcCtD
Rufinamide—Vomiting—Epirubicin—prostate cancer	3.56e-05	0.00021	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—prostate cancer	3.54e-05	0.000209	CcSEcCtD
Rufinamide—Rash—Epirubicin—prostate cancer	3.53e-05	0.000208	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—prostate cancer	3.52e-05	0.000208	CcSEcCtD
Rufinamide—Headache—Epirubicin—prostate cancer	3.5e-05	0.000207	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—prostate cancer	3.42e-05	0.000202	CcSEcCtD
Rufinamide—Nausea—Epirubicin—prostate cancer	3.32e-05	0.000196	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—prostate cancer	3.29e-05	0.000194	CcSEcCtD
Rufinamide—Rash—Doxorubicin—prostate cancer	3.26e-05	0.000192	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—prostate cancer	3.26e-05	0.000192	CcSEcCtD
Rufinamide—Headache—Doxorubicin—prostate cancer	3.24e-05	0.000191	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—prostate cancer	3.07e-05	0.000181	CcSEcCtD
Rufinamide—ALB—Metabolism—SLC22A3—prostate cancer	6.78e-06	5.93e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSD3B1—prostate cancer	6.78e-06	5.93e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PLCB2—prostate cancer	6.74e-06	5.9e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2C18—prostate cancer	6.74e-06	5.9e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LRP2—prostate cancer	6.74e-06	5.9e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UGT2B17—prostate cancer	6.68e-06	5.84e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CKMT2—prostate cancer	6.68e-06	5.84e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UGT2B15—prostate cancer	6.68e-06	5.84e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GRHPR—prostate cancer	6.68e-06	5.84e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—P4HB—prostate cancer	6.61e-06	5.78e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	6.58e-06	5.75e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	6.51e-06	5.7e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA4—prostate cancer	6.5e-06	5.69e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TBXAS1—prostate cancer	6.5e-06	5.69e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC22A1—prostate cancer	6.43e-06	5.62e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	6.35e-06	5.56e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	6.34e-06	5.55e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA2—prostate cancer	6.33e-06	5.54e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RFK—prostate cancer	6.28e-06	5.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AOX1—prostate cancer	6.28e-06	5.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NAGLU—prostate cancer	6.28e-06	5.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM3—prostate cancer	6.28e-06	5.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MBTPS1—prostate cancer	6.28e-06	5.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SULT2B1—prostate cancer	6.28e-06	5.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PGAM2—prostate cancer	6.28e-06	5.49e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—prostate cancer	6.27e-06	5.48e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SULT2A1—prostate cancer	6.27e-06	5.48e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCG5—prostate cancer	6.26e-06	5.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SULT1A1—prostate cancer	6.26e-06	5.47e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MED12—prostate cancer	6.17e-06	5.39e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAU—prostate cancer	6.14e-06	5.37e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GNG5—prostate cancer	6.12e-06	5.35e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA1—prostate cancer	6.11e-06	5.35e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—prostate cancer	6.11e-06	5.34e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—prostate cancer	6.06e-06	5.3e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NAT2—prostate cancer	6.04e-06	5.29e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTO1—prostate cancer	6.04e-06	5.29e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSD3B2—prostate cancer	6.04e-06	5.29e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CAV1—prostate cancer	6e-06	5.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AMACR—prostate cancer	5.95e-06	5.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP3A43—prostate cancer	5.95e-06	5.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—DEGS1—prostate cancer	5.95e-06	5.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SRD5A2—prostate cancer	5.95e-06	5.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NAT1—prostate cancer	5.95e-06	5.21e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOA3—prostate cancer	5.89e-06	5.15e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	5.82e-06	5.09e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.81e-06	5.08e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLCB2—prostate cancer	5.79e-06	5.07e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2C18—prostate cancer	5.79e-06	5.07e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LRP2—prostate cancer	5.79e-06	5.07e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—P4HB—prostate cancer	5.68e-06	4.97e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD17B1—prostate cancer	5.68e-06	4.97e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—prostate cancer	5.64e-06	4.93e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HPGDS—prostate cancer	5.62e-06	4.92e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2C19—prostate cancer	5.59e-06	4.89e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—prostate cancer	5.55e-06	4.86e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC22A1—prostate cancer	5.53e-06	4.83e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	5.53e-06	4.83e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—prostate cancer	5.47e-06	4.78e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.46e-06	4.78e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTT1—prostate cancer	5.45e-06	4.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ACHE—prostate cancer	5.45e-06	4.77e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EGF—prostate cancer	5.4e-06	4.73e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2A6—prostate cancer	5.39e-06	4.71e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SULT2A1—prostate cancer	5.39e-06	4.71e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MED12—prostate cancer	5.3e-06	4.63e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GNG5—prostate cancer	5.26e-06	4.6e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKR1C3—prostate cancer	5.24e-06	4.59e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PRKACB—prostate cancer	5.21e-06	4.56e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP17A1—prostate cancer	5.16e-06	4.51e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—prostate cancer	5.12e-06	4.48e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CREBBP—prostate cancer	5.07e-06	4.43e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOA3—prostate cancer	5.06e-06	4.43e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HPGD—prostate cancer	5.06e-06	4.43e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—B4GALT4—prostate cancer	5.06e-06	4.43e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF1—prostate cancer	5e-06	4.38e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.98e-06	4.35e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	4.95e-06	4.33e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOA2—prostate cancer	4.92e-06	4.3e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HPGDS—prostate cancer	4.83e-06	4.23e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CD—prostate cancer	4.81e-06	4.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2C19—prostate cancer	4.8e-06	4.2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	4.76e-06	4.16e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SERPINE1—prostate cancer	4.75e-06	4.16e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC5A5—prostate cancer	4.69e-06	4.1e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ACHE—prostate cancer	4.69e-06	4.1e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTT1—prostate cancer	4.69e-06	4.1e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2A6—prostate cancer	4.63e-06	4.05e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP7B1—prostate cancer	4.63e-06	4.05e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTAP—prostate cancer	4.63e-06	4.05e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.61e-06	4.04e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS3—prostate cancer	4.54e-06	3.97e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NQO1—prostate cancer	4.53e-06	3.96e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SULT1E1—prostate cancer	4.51e-06	3.95e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SRD5A1—prostate cancer	4.51e-06	3.95e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKR1C3—prostate cancer	4.51e-06	3.94e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PRKACB—prostate cancer	4.48e-06	3.92e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TH—prostate cancer	4.47e-06	3.91e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP17A1—prostate cancer	4.44e-06	3.88e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP3A4—prostate cancer	4.42e-06	3.86e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—JAK2—prostate cancer	4.41e-06	3.86e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.39e-06	3.84e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.37e-06	3.83e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1B1—prostate cancer	4.34e-06	3.8e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.3e-06	3.76e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ACSL4—prostate cancer	4.3e-06	3.76e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOA2—prostate cancer	4.23e-06	3.7e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GGT1—prostate cancer	4.21e-06	3.68e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CB—prostate cancer	4.19e-06	3.66e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOA1—prostate cancer	4.14e-06	3.62e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UMPS—prostate cancer	4.13e-06	3.61e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ARG2—prostate cancer	4.13e-06	3.61e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PHGDH—prostate cancer	4.13e-06	3.61e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP19A1—prostate cancer	4.08e-06	3.57e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LDHB—prostate cancer	4.05e-06	3.54e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	4.05e-06	3.54e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC5A5—prostate cancer	4.03e-06	3.53e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.97e-06	3.47e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RXRA—prostate cancer	3.94e-06	3.45e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2E1—prostate cancer	3.94e-06	3.44e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NQO1—prostate cancer	3.89e-06	3.41e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—prostate cancer	3.85e-06	3.36e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TH—prostate cancer	3.84e-06	3.36e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PDHA1—prostate cancer	3.84e-06	3.36e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA3—prostate cancer	3.84e-06	3.36e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TCN2—prostate cancer	3.84e-06	3.36e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UCP3—prostate cancer	3.84e-06	3.36e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.81e-06	3.34e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP3A4—prostate cancer	3.8e-06	3.32e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—COMT—prostate cancer	3.8e-06	3.32e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTP1—prostate cancer	3.78e-06	3.31e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.78e-06	3.3e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1B1—prostate cancer	3.73e-06	3.27e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ITPR1—prostate cancer	3.72e-06	3.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.66e-06	3.2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.66e-06	3.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GGT1—prostate cancer	3.62e-06	3.16e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOA1—prostate cancer	3.56e-06	3.12e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TYMS—prostate cancer	3.51e-06	3.07e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP19A1—prostate cancer	3.51e-06	3.07e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.51e-06	3.07e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA4—prostate cancer	3.51e-06	3.07e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—prostate cancer	3.47e-06	3.04e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EP300—prostate cancer	3.45e-06	3.02e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA2—prostate cancer	3.42e-06	2.99e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LPL—prostate cancer	3.41e-06	2.98e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RXRA—prostate cancer	3.39e-06	2.96e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCG5—prostate cancer	3.38e-06	2.95e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.38e-06	2.95e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—prostate cancer	3.36e-06	2.94e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA1—prostate cancer	3.3e-06	2.89e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.29e-06	2.88e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1A1—prostate cancer	3.29e-06	2.88e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—prostate cancer	3.27e-06	2.86e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ERCC2—prostate cancer	3.27e-06	2.86e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—COMT—prostate cancer	3.26e-06	2.85e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.26e-06	2.85e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NAT2—prostate cancer	3.26e-06	2.85e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTO1—prostate cancer	3.26e-06	2.85e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTP1—prostate cancer	3.25e-06	2.84e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ITPR1—prostate cancer	3.2e-06	2.8e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.14e-06	2.75e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLCB2—prostate cancer	3.13e-06	2.74e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LRP2—prostate cancer	3.13e-06	2.74e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.13e-06	2.74e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—prostate cancer	3.07e-06	2.68e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—P4HB—prostate cancer	3.07e-06	2.68e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TYMS—prostate cancer	3.02e-06	2.64e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARA—prostate cancer	3.01e-06	2.63e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—prostate cancer	3e-06	2.62e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—prostate cancer	2.98e-06	2.61e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.98e-06	2.61e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LPL—prostate cancer	2.93e-06	2.56e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.91e-06	2.54e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MED12—prostate cancer	2.86e-06	2.5e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GNG5—prostate cancer	2.84e-06	2.48e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAV1—prostate cancer	2.83e-06	2.48e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1A1—prostate cancer	2.83e-06	2.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ERCC2—prostate cancer	2.81e-06	2.45e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—prostate cancer	2.78e-06	2.43e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOA3—prostate cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—prostate cancer	2.64e-06	2.31e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HPGDS—prostate cancer	2.61e-06	2.28e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.59e-06	2.27e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARA—prostate cancer	2.59e-06	2.26e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—prostate cancer	2.58e-06	2.26e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—prostate cancer	2.55e-06	2.23e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ACHE—prostate cancer	2.53e-06	2.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTT1—prostate cancer	2.53e-06	2.21e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.5e-06	2.19e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—prostate cancer	2.47e-06	2.16e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—INS—prostate cancer	2.44e-06	2.13e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAV1—prostate cancer	2.43e-06	2.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.43e-06	2.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PRKACB—prostate cancer	2.42e-06	2.12e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.39e-06	2.09e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CREBBP—prostate cancer	2.39e-06	2.09e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.32e-06	2.03e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOA2—prostate cancer	2.28e-06	2e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CD—prostate cancer	2.27e-06	1.98e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—prostate cancer	2.22e-06	1.94e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.18e-06	1.9e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NOS3—prostate cancer	2.14e-06	1.87e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.13e-06	1.86e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NQO1—prostate cancer	2.1e-06	1.84e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—INS—prostate cancer	2.1e-06	1.83e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—prostate cancer	2.09e-06	1.82e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TH—prostate cancer	2.07e-06	1.81e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CREBBP—prostate cancer	2.05e-06	1.8e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.02e-06	1.76e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.98e-06	1.73e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—prostate cancer	1.96e-06	1.71e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GGT1—prostate cancer	1.95e-06	1.71e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CD—prostate cancer	1.95e-06	1.7e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOA1—prostate cancer	1.92e-06	1.68e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.89e-06	1.66e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NOS3—prostate cancer	1.84e-06	1.61e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RXRA—prostate cancer	1.83e-06	1.6e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COMT—prostate cancer	1.76e-06	1.54e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTP1—prostate cancer	1.75e-06	1.53e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ITPR1—prostate cancer	1.73e-06	1.51e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—prostate cancer	1.71e-06	1.49e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CB—prostate cancer	1.7e-06	1.49e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—prostate cancer	1.68e-06	1.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TYMS—prostate cancer	1.63e-06	1.43e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—EP300—prostate cancer	1.63e-06	1.42e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—prostate cancer	1.61e-06	1.41e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LPL—prostate cancer	1.58e-06	1.38e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.53e-06	1.34e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ERCC2—prostate cancer	1.51e-06	1.32e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—prostate cancer	1.47e-06	1.28e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—prostate cancer	1.42e-06	1.25e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—EP300—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARA—prostate cancer	1.4e-06	1.22e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAV1—prostate cancer	1.31e-06	1.15e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.2e-06	1.05e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.2e-06	1.05e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—INS—prostate cancer	1.13e-06	9.91e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CREBBP—prostate cancer	1.11e-06	9.7e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.05e-06	9.2e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—prostate cancer	1.04e-06	9.05e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NOS3—prostate cancer	9.93e-07	8.69e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—prostate cancer	9.84e-07	8.61e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CB—prostate cancer	9.17e-07	8.02e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—prostate cancer	9.08e-07	7.94e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—prostate cancer	8.46e-07	7.4e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—prostate cancer	7.92e-07	6.93e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—EP300—prostate cancer	7.55e-07	6.61e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.59e-07	4.89e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—prostate cancer	4.57e-07	3.99e-06	CbGpPWpGaD
